[go: up one dir, main page]

AUPP999799A0 - New compound - Google Patents

New compound

Info

Publication number
AUPP999799A0
AUPP999799A0 AUPP9997A AUPP999799A AUPP999799A0 AU PP999799 A0 AUPP999799 A0 AU PP999799A0 AU PP9997 A AUPP9997 A AU PP9997A AU PP999799 A AUPP999799 A AU PP999799A AU PP999799 A0 AUPP999799 A0 AU PP999799A0
Authority
AU
Australia
Prior art keywords
new compound
compound
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPP9997A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to AUPP9997A priority Critical patent/AUPP999799A0/en
Publication of AUPP999799A0 publication Critical patent/AUPP999799A0/en
Priority to US09/926,385 priority patent/US6884868B1/en
Priority to EP00917469A priority patent/EP1173472A1/en
Priority to PCT/JP2000/002710 priority patent/WO2000064927A1/en
Priority to JP2000614276A priority patent/JP2003501347A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AUPP9997A 1999-04-27 1999-04-27 New compound Abandoned AUPP999799A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AUPP9997A AUPP999799A0 (en) 1999-04-27 1999-04-27 New compound
US09/926,385 US6884868B1 (en) 1999-04-27 2000-04-25 Cyclic hexapeptides having antibiotic activity
EP00917469A EP1173472A1 (en) 1999-04-27 2000-04-25 Cyclic hexapeptides having antibiotic activity
PCT/JP2000/002710 WO2000064927A1 (en) 1999-04-27 2000-04-25 Cyclic hexapeptides having antibiotic activity
JP2000614276A JP2003501347A (en) 1999-04-27 2000-04-25 Hexapeptide compound with antibacterial activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPP9997A AUPP999799A0 (en) 1999-04-27 1999-04-27 New compound

Publications (1)

Publication Number Publication Date
AUPP999799A0 true AUPP999799A0 (en) 1999-05-20

Family

ID=3814198

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPP9997A Abandoned AUPP999799A0 (en) 1999-04-27 1999-04-27 New compound

Country Status (5)

Country Link
US (1) US6884868B1 (en)
EP (1) EP1173472A1 (en)
JP (1) JP2003501347A (en)
AU (1) AUPP999799A0 (en)
WO (1) WO2000064927A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR362001A0 (en) * 2001-03-08 2001-04-05 Fujisawa Pharmaceutical Co., Ltd. New compound
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
MXPA05010713A (en) * 2003-04-04 2006-05-19 Univ Texas Polyamine/alkali salt blends for carbon dioxide removal from gas streams.
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903629A0 (en) * 2003-07-14 2003-07-31 Fujisawa Pharmaceutical Co., Ltd. New compound
US20080306124A1 (en) * 2005-06-08 2008-12-11 Rainer Albert Polycyclic Oxadiazoles or I Soxazoles and Their Use as Sip Receptor Ligands
ES2558152T3 (en) 2007-06-08 2016-02-02 Janssen Pharmaceutica, N.V. Piperidine / Piperazine Derivatives
AR066911A1 (en) * 2007-06-08 2009-09-23 Janssen Pharmaceutica Nv PIPERIDINE / PIPERAZINE DERIVATIVES
WO2008148851A1 (en) * 2007-06-08 2008-12-11 Janssen Pharmaceutica N.V. Piperidine/piperazine derivatives
JO2972B1 (en) 2007-06-08 2016-03-15 جانسين فارماسوتيكا ان. في Piperidine/Piperazine derivatives
JP6144450B2 (en) 2007-10-04 2017-06-07 メルク セローノ ソシエテ アノニム Oxadiazole derivatives
WO2009043890A1 (en) 2007-10-04 2009-04-09 Merck Serono S.A. Oxadiazole diaryl compounds
BRPI0820409A2 (en) 2007-10-29 2015-05-19 Astellas Pharma Inc Polypeptide Compound
ES2617619T3 (en) 2008-06-05 2017-06-19 Janssen Pharmaceutica, N.V. Drug combinations comprising a DGAT inhibitor and a PPAR agonist
BRPI0914629A2 (en) * 2008-06-24 2019-09-24 Irm Llc compounds and methods for modulating g protein-coupled receptors
AU2016380349B2 (en) * 2015-12-30 2020-10-29 Nqp 1598, Ltd. Metalloenzyme inhibitor compounds
CN116178296A (en) * 2023-03-02 2023-05-30 广东新达瑞生物科技有限公司 Preparation method of micafungin side chain and preparation method of micafungin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE990233A1 (en) 1990-06-18 2000-11-15 Fujisawa Pharmaceutical Co New Polypeptide Compound and a Process for Preparation thereof
US5939384A (en) 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
IL109615A (en) * 1993-05-17 2000-12-06 Fujisawa Pharmaceutical Co Cyclic polypeptide derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
US6107458A (en) * 1994-10-07 2000-08-22 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity
AUPO371596A0 (en) 1996-11-19 1996-12-12 Fujisawa Pharmaceutical Co., Ltd. New compound
AUPO691897A0 (en) 1997-05-21 1997-06-12 Fujisawa Pharmaceutical Co., Ltd. New compound
CN1240713C (en) 1998-02-09 2006-02-08 藤泽药品工业株式会社 New compound

Also Published As

Publication number Publication date
US6884868B1 (en) 2005-04-26
EP1173472A1 (en) 2002-01-23
WO2000064927A1 (en) 2000-11-02
JP2003501347A (en) 2003-01-14

Similar Documents

Publication Publication Date Title
AU5413600A (en) Compounds
AU1278701A (en) Novel compounds
AUPP796798A0 (en) New compound
AU2408300A (en) Novel compounds
AUPP999799A0 (en) New compound
AUPQ441499A0 (en) Novel compound
AU6032100A (en) New compounds
AU1746401A (en) Compounds
AU3997700A (en) Anti-first-pass effect compounds
AUPP549998A0 (en) New compound
AU4132200A (en) Novel compounds
AU2109700A (en) Novel compounds
AU5787901A (en) Compound
AU6567400A (en) Substituted 2-imino-thiazolines
AU5119400A (en) Compounds
AU2668000A (en) Bis-styrylbiphenyl compounds
AU4156800A (en) Novel compounds
AU2288900A (en) Novel compounds
AU6168900A (en) Compounds
AU1385701A (en) Novel compounds
AU7784700A (en) Novel compounds
AUPQ357699A0 (en) New compound WF217
AU6831100A (en) Substituted heterocyclybenzofuranes
AU2194201A (en) Novel compound
AUPP831199A0 (en) New compound